Alpha-fetoprotein following neonatal resection of sacrococcygeal teratoma

Pediatric Hematology and Oncology

Volumn 23, Issue 4, 2006, Pages 287-291

  Guimarães Barreto, Maria Weber ^a   Silva, Luciana Vivas ^a   Barini, Ricardo ^a   Oliveira Filho, Antonio Gonçalves ^a   Sbragia, Lourenço ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

fetoprotein; Prenatal diagnosis; Sacrococcygeal teratoma

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CELLULITIS; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROGENIC BLADDER; NEWBORN; NEWBORN SURGERY; PRENATAL DIAGNOSIS; PROTEIN BLOOD LEVEL; SACROCOCCYX TERATOMA;

ALPHA-FETOPROTEINS; CELLULITIS; FEMALE; HUMANS; INFANT, NEWBORN; MALE; POSTOPERATIVE COMPLICATIONS; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; SACROCOCCYGEAL REGION; TERATOMA; TIME FACTORS;

EID: 33646364373     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010600629056     Document Type: Article

References (15)

1. Winderl LM, Silverman LK. Prenatal identification of a completely cystic internal sacrococcygeal teratoma (type IV). Ultrasound Obstet Gynecol. 1997;9:425-428.
2. Ballantyne JW. Teratologie. City: Williams & Nougate; 1874.
3. Crussi FG, Wrinkler RF, Mirkin DL. Sacrococcygeal teratoma in infants and children. Arch Pathol Lab Med. 1978;102:402-405.
4. Bilik R, Shandling B, Pope M, et al. Malignant benign neonatal sacrococcygeal teratoma. J Pediatr Surg. 1993;28:1158-1160.
5. Lubchenco LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics. 1966;37:403-408.
6. Brenner WE, Edelman DA, Hendricks CH. A standard of fetal growth for the United States of America. Am J Obstet Gynecol. 1976;126:555-564.
7. Murphy JJ, Blair GK, Fraser GC. Coagulopathy associated with large sacrococcygeal teratomas. J Pediatr Surg. 1992;27:1308-1310.
8. Bond SJ, Harrison MR, Schmidt KG, et al. Death due to high-output cardiac failure in fetal sacrococcygeal teratoma. J Pediatr Surg. 1990;25:1287-1291.
9. Kum CK, Wong YC, Prabhakaram K. Management of fetal sacrococcygeal teratoma. Ann Acad Med. 1993;22:377-380.
10. Holterman A, Filiatraut D, Lallier M, et al. The natural history of sacrococcygeal teratomas diagnosed through routine obstetric sonogram: a single institution experience. J Pediatr Surg. 2000;33:899-903.
11. Heerema-McKenney A, Harrison MR, Bratton B, Farrell J, Zaloudek C. Congenital teratoma: a clinicopathologic study of 22 fetal and neonatal tumors. Am J Surg Pathol. 2005;29:29-38.
12. Brinker MR, Sheldin RG, Moynihan PC. Sacrococcygeal teratoma in children. J La State Med Soc. 1989;141:26-31.
13. Dewan PA, Davidson PM, Campbell PE. Sacrococcygeal teratoma: has chemotherapy improved survival? J Pediatr Surg. 1987;22:274-227.
14. Brewer JA, Tank ES. Yolk sac tumors and alpha-fetoprotein. Urology. 1993;42:79-80.
15. Han SJ, Yoo S, Choi SH, Hwang EH. Actual half-life of alpha-fetoprotein as a prognostic tool in pediatric malignant tumors. Pediatr Surg Int. 1997;12:599-602.